Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Thu, 26.09.2024
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma, Gerresheimer, and Stevanato Group announce strategic industry “Alliance for RTU”
Market advances adoption of ready-to-use containers
Improved operational efficiency in pharmaceutical manufacturing processes
Increased patient safety with high-quality sterile primary packaging
SCHOTT Pharma AG & Co. KGaA (MDAX: 1SXP), a pioneer [ … ]
Thu, 26.09.2024
Gerresheimer AG
Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU”
Market advances adoption of ready-to-use containers
Improved operational efficiency in pharmaceutical manufacturing processes
Increased patient safety with high-quality sterile primary packaging
Düsseldorf, September 26, 2024. Gerresheimer AG (MDAX: G [ … ]
Thu, 26.09.2024
GEA Group Aktiengesellschaft
GEA and Believer Meats join forces to scale up cultivated meat production
Wilson (USA) / Duesseldorf (Germany), September 26, 2024 – Believer Meats, a pioneer in the cultivated meat industry, has signed a strategic partnership agreement with GEA, one of the world’s largest suppliers of production scale equipment and systems to the food, beverage, [ … ]
Thu, 26.09.2024
Semperit AG Holding
Semperit: Manfred Stanek appointed new CEO
Vienna, 26 September 2024 – The Supervisory Board of Semperit AG Holding appointed Manfred Stanek as the new CEO of Semperit AG Holding today. He will join the Executive Board on 1March 2025 and take over the role of CEO on 1 April 2025; his mandate as a member of the Executive Board will run until 29 Fe [ … ]
Thu, 26.09.2024
PUMA SE
PRESS RELEASE
PUMA appoints Markus Neubrand as Chief Financial Officer
Herzogenaurach, September 26, 2024 – Sports company PUMA has appointed Markus Neubrand (48) as its Chief Financial Officer (CFO) and a member of the Management Board, effective October 1, 2024. The contract of the current CFO Hubert Hinterseher will end by mutual agr [ … ]
Thu, 26.09.2024
tick Trading Software AG
Düsseldorf, September 26, 2024 – tick Trading Software AG (tick-TS), a leading service provider in securities trading, will participate in this year's Singapore FinTech Festival (SFF) with a booth in the German Pavilion. This global event, taking place from November 6-8, 2024, offers a unique platform for tapping into new markets and discovering th [ … ]
Thu, 26.09.2024
Edison Investment Research Limited
London, UK, 26 September 2024
Edison issues report on Henderson International Income Trust (HINT)
Edison issues report on Henderson International Income Trust (LSE: HINT).
Henderson International Income Trust (HINT) seeks out companies with potential for growth from exposure to structural themes that is not priced into their valuations. Th [ … ]
Thu, 26.09.2024
Hardman & Co Research
Hardman & Co Research on Chesnara Plc (CSN): Steady as she goes!
Chesnara has announced its 1H’24 results. The main features were positive equity market returns, offset to some extent by further adverse lapse experience. Economic Value profit of £20.2m was behind the 1H’23 result of £32.6m (excl. acquisitions). Economic Value saw a small de [ … ]
Thu, 26.09.2024
Commerzbank Aktiengesellschaft
Chairman of the Supervisory Board Jens Weidmann: Commerzbank has considerable potential for growth and appreciation
The Board of Management expects faster and stronger improvements in profitability: Return on equity is expected to rise to more than 12% by 2027
Increased and accelerated capital return to shareholders planned
During the annual stra [ … ]
Thu, 26.09.2024
ABIVAX
Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
Professor Bruce E. Sands, MD to present oral presentation of Phase 2b, open-label, maintenance efficacy and safety data at weeks 48 and 96 among week 8 induction non-responders in obefazimod-treated patients with moderately to severely active ulcerative col [ … ]